Novo Nordisk: Why the stock of the Danish pharmaceutical giant is plunging

Emily Field, Barclays head of European pharmaceutical research, joins CNBC’s ‘The Exchange’ to discuss why Novo Nordisk shares are falling, the competition in the weight-loss drug space, and more.